Thermography, or "MammoTherms," employ a heat-sensing scanner
to detect variations in the temperature of breast tissue. The
been around since the 1960s, however, early infrared scanners were
not very sensitive and they were insufficiently tested before being
put into clinical practice. This resulted in misdiagnosed cases.
technology is vastly improved
and more extensive scientific clinical breast thermography research
is available, with data from major peer review journals and research
on more than 300,000 women who have been tested. It has been
successful in detecting breast cancer more accurately than other
methods, and the technology is also gaining ground among more
progressive practitioners, such as the Health Medicine Center.
thermography has demonstrated a higher degree of success
in identifying women with breast cancer under the age of 55 in
comparison to other technologies, and it's also an effective adjunct
to clinical breast exams and mammography for women over 55. Finally,
it provides a non-invasive and safe detection method, and if
introduced at age 25, provides a benchmark that future scans can be
compared with for even greater detection accuracy.
This thermal imaging technology has
been validated as effective and approved by the FDA for breast
cancer risk assessment. Recent studies have documented that
thermography, as a single test, has 99% accuracy in identifying
breast cancer in women in the 30 to 55 age group. For women over 55
the accuracy is still an impressive 95%.